Highlights Orgenesis Inc.

Stocks

ORGS

US68619K3032

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 07:33:35 11/06/2026 pm IST			5-day change	1st Jan Change
0.4950 ^USD	+23.75%		+1.02%	+230.00%

26/03	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
26/03	Orgenesis Inc. Auditor Raises 'Going Concern' Doubt	CI

Highlights

26/03	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
26/03	Okogen, Inc. acquired Global intellectual property portfolio and development assets for ranpirnase from Orgenesis Inc..	CI
06/25/06	Orgenesis Inc. completed the acquisition of Certain assets of Neurocords LLC for $5.7 million.	CI
13/24/13	Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020.	CI
13/24/13	Orgenesis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
23/24/23	Orgenesis Board Approves 1-for-10 Reverse Stock Split	MT
29/24/29	Orgenesis Announces Positive Results from Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia	CI
15/24/15	Sector Update: Health Care Stocks Rise Late Afternoon	MT
14/24/14	Orgenesis Shares Jump After Harley Street Agrees to Invest $10 Million, Form JV	MT
14/24/14	Orgenesis Inc. Announces Strategic Partnership with Harley Street Healthcare Group to Launch A Longevity & Wellness Initiative Globally	CI
09/24/09	Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020.	CI
09/24/09	Orgenesis Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
12/24/12	Orgenesis Inc. agreed to acquire remaining 50% stake in Theracell Laboratories SA. from Theracell Advanced Biotechnology Ltd for $13 million.	CI
21/24/21	Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020.	CI
21/24/21	Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/24/16	Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020.	CI
16/24/16	Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
10/24/10	Germfree and Orgenesis Inc. Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility	CI
31/24/31	Orgenesis Inc. agreed to acquire 25% stake in Octomera LLC from MM OS Holdings, L.P.	CI
24/24/24	Orgenesis Inc. entered into a binding Term Sheet agreement to acquire Octomera LLC from MM OS Holdings, L.P.	CI
14/23/14	Earnings Flash (ORGS) ORGENESIS Reports Q3 Revenue $110,000	MT
14/23/14	Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020.	CI
14/23/14	Orgenesis Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
21/23/21	CGT Global and Octomera Enter Agreement to Expand Cell & Gene Therapy Development and Patient Access Across the United States	CI
11/23/11	Tranche Update on Orgenesis Inc.'s Equity Buyback Plan announced on May 15, 2020.	CI